Novo Nordisk says it is gradually phasing out human insulin pens globally
Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...
Novo Nordisk to phase out human insulin pens: report
Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other ...
Medical News Today10d
NovoLog interactions: Alcohol, medications, and other factors
NovoLog (insulin aspart) is a brand-name injectable ... NovoLog comes as a solution for subcutaneous injection or intravenous (IV) infusion in certain situations. To learn more about NovoLog ...
Humanitarian Organization Criticizes Eli Lilly, Novo Nordisk And Sanofi Of Having 'Double Standards' For High Insulin Price
MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...
Yahoo22d
Diabetes patients worry about insulin shortages as Ozempic use skyrockets
Her neighborhood Fred Meyer pharmacy in Anchorage, Alaska, hadn't called in weeks to offer an automatic refill, and Wright's supply of NovoLog insulin had dwindled to nearly nothing. The 62-year ...
Business Line1mon
Wockhardt seeks DCGI approval on its version of Aspart insulin
Drugmaker Wockhardt has approached the Drug Controller General of India (DCGI) seeking approvals for its fast-acting insulin analog, Aspart injection ... sold globally as NovoLog or NovoRapid.